Zhifei Wang
- Cancer Research top 10%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 3
-
- Circular RNAs in diseases 7
- RNA modifications and cancer 3
- Extracellular vesicles in disease 2
-
- Intracranial Aneurysms: Treatment and Complications 5
- Intracerebral and Subarachnoid Hemorrhage Research 5
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Fan LiaoJin DaiHao WuTao CaiQiang LiuGuangyong WuKui LuoFang Jia-sheng
- Journals
- The FASEB Journal (1 paper)Experimental Neurology (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Zhifei Wang
23 papers receiving 527 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 303
- Molecular Biology 424
- Genetics 54
- Molecular Medicine 17
- Neurology 37
Countries citing papers authored by Zhifei Wang
This map shows the geographic impact of Zhifei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifei Wang more than expected).
Fields of papers citing papers by Zhifei Wang
This network shows the impact of papers produced by Zhifei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifei Wang. The network helps show where Zhifei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhifei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 10 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2022 | 29 | |
| 5 | 2022 | 15 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 9 | |
| 9 | 2019 | 147 | |
| 10 | 2018 | 10 | |
| 11 | 2017 | 16 | |
| 12 | 2015 | 51 | |
| 13 | 2014 | 39 | |
| 14 | 2014 | 17 | |
| 15 | 2013 | 5 | |
| 16 | 2013 | 34 | |
| 17 | 2013 | 27 | |
| 18 | [Role of matrix metalloproteinase in transformation of subdural effusion into chronic subdural hematoma]. | 2010 | 3 |
| 19 | 2009 | 16 | |
| 20 | [CT angiography-based simulation of the surgical approach in early operation for ruptured aneurysm]. | 2009 | 1 |
About Zhifei Wang
Zhifei Wang is a scholar working on Cancer Research, Neurology and Biochemistry, having authored 24 papers that have together received 535 indexed citations. Recurring topics across this work include Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (6 papers), Intracranial Aneurysms: Treatment and Complications (5 papers), Intracerebral and Subarachnoid Hemorrhage Research (5 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Extracellular vesicles in disease (2 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Cancer Research (303 citations), Molecular Biology (424 citations) and Genetics (54 citations). Zhifei Wang has collaborated with scholars based in China and United States. Frequent co-authors include Fan Liao, Jin Dai, Hao Wu, Tao Cai, Hao Wu, Qiang Liu, Qiang Liu, Guangyong Wu, Hao Wu and Kui Luo. Their work appears in journals such as The FASEB Journal, Experimental Neurology and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.